The stock of Kairos Pharma Ltd (AMEX: KAPA) has increased by 51.05 when compared to last closing price of 1.36.Despite this, the company has seen a gain of 53.31% in its stock price over the last five trading days. globenewswire.com reported 2024-10-22 that LOS ANGELES, Oct. 22, 2024 (GLOBE NEWSWIRE) — Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announced today that John S. Yu, M.D., Chief Executive Officer, will present a corporate overview at the LD Micro Main Event XVII. The conference is being held on October 28 – 30, 2024 at the Luxe Sunset Boulevard Hotel in Los Angeles.
Is It Worth Investing in Kairos Pharma Ltd (AMEX: KAPA) Right Now?
Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for KAPA is 6.14M, and currently, shorts hold a 0.11% of that float. The average trading volume for KAPA on November 13, 2024 was 140.88K shares.
KAPA’s Market Performance
The volatility ratio for the week is 17.97%, and the volatility levels for the past 30 days are at 12.74% for Kairos Pharma Ltd The simple moving average for the past 20 days is 43.10% for KAPA’s stock, with a 29.28% simple moving average for the past 200 days.
KAPA Trading at 29.28% from the 50-Day Moving Average
After a stumble in the market that brought KAPA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -48.64% of loss for the given period.
Volatility was left at 12.74%, however, over the last 30 days, the volatility rate increased by 17.97%, as shares surge +32.26% for the moving average over the last 20 days.
During the last 5 trading sessions, KAPA rose by +52.99%, in comparison to the 20-day moving average, which settled at $1.4400. In addition, Kairos Pharma Ltd saw -20.99% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for KAPA
The liquidity ratio also appears to be rather interesting for investors as it stands at 0.01.
Conclusion
In conclusion, Kairos Pharma Ltd (KAPA) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
